Point72 Hong Kong LTD Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $1.32 Million - $1.67 Million	2,300 Added 115.0%	4,300 $2.96 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $164,505 - $221,652	-300 Reduced 13.04%	2,000 $1.18 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $1.73 Million - $2.03 Million	-2,900 Reduced 55.77%	2,300 $1.61 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $57,403 - $68,096	100 Added 1.96%	5,200 $3.15 Million
Q2 2021 Aug 16, 2021	BUY	$472.8 - $558.54 $2.17 Million - $2.57 Million	4,600 Added 920.0%	5,100 $2.85 Million
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $223,365 - $274,100	500 New	500 $237,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.